Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Danenberg

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapyY Shirota, J Stoehlmacher, J Brabender, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and siteH J Lenz, K D Danenberg, C G Leichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineP Ceppi, M Volante, S Novello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survivalH J Lenz, K Hayashi, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylaseD Salonga, K D Danenberg, M Johnson, et al.
Investigative Ophthalmology & Visual Science|November 1, 1993
Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reactionJ Kan-Mitchell, P E Liggett, C R Taylor, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 27, 2006
Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagusD Vallböhmer, S R DeMeester, J H Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survivalH J Lenz, C G Leichman, K D Danenberg, et al.
Cancer Letters|October 6, 1997
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapyM Kornmann, K H Link, H J Lenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivityJ F Ju, D Banerjee, H J Lenz, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapyY Shirota, J Stoehlmacher, J Brabender, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and siteH J Lenz, K D Danenberg, C G Leichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineP Ceppi, M Volante, S Novello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survivalH J Lenz, K Hayashi, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylaseD Salonga, K D Danenberg, M Johnson, et al.
Investigative Ophthalmology & Visual Science|November 1, 1993
Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reactionJ Kan-Mitchell, P E Liggett, C R Taylor, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 27, 2006
Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagusD Vallböhmer, S R DeMeester, J H Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survivalH J Lenz, C G Leichman, K D Danenberg, et al.
Cancer Letters|October 6, 1997
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapyM Kornmann, K H Link, H J Lenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivityJ F Ju, D Banerjee, H J Lenz, et al.
Pageof 6